23 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• TRACON Pharmaceuticals, Inc. TCON stock rose 18.5% to $0.64 during Thursday's pre-market session. The market cap stands at $74.3 million. The most recent rating by H.C. Wainwright, on August 29, is at Buy, with a price target of $2.00.
• Plus Therapeutics, Inc. PSTV shares surged 14.3% to $22.00. The market cap seems to be at $226.6 million.
• Edap TMS, Inc. EDAP shares moved upwards by 11.1% to $3.80. The market cap stands at $86.9 million.
• Otonomy, Inc. OTIC shares rose 7.9% to $2.33. The market cap seems to be at $75.9 million. The most recent rating by H.C. Wainwright, on August 29, is at Buy, with a price target of $8.00.
• Cancer Genetics, Inc. CGIX stock rose 7.8% to $0.09. The market cap seems to be at $37.0 million.
• Acasti Pharma, Inc. ACST shares surged 7.6% to $1.84. The market value of their outstanding shares is at $25.6 million. The most recent rating by Oppenheimer, on July 18, is at Outperform, with a price target of $7.00.
• Soligenix, Inc. SNGX stock increased by 6.4% to $1.17. The market cap stands at $16.6 million.
• Kitov Pharma, Inc. KTOV stock increased by 5.1% to $0.75. The market value of their outstanding shares is at $28.6 million.
• Histogenics, Inc. HSGX stock surged 4.4% to $0.24. The market cap seems to be at $52.8 million.
• Esperion Therapeutics, Inc. ESPR stock rose 4.2% to $37.50. The market cap stands at $335.0 million.
• Therapix Biosciences, Inc. TRPX stock rose 3.7% to $2.50. The market cap stands at $8.3 million.
• Radius Health, Inc. RDUS stock surged 3.2% to $25.70. The market cap stands at $1.3 billion. The most recent rating by Citigroup, on August 29, is at Buy, with a price target of $40.00.
• Aphria, Inc. APHA stock increased by 3.0% to $6.40. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Zynerba Pharmaceuticals, Inc. ZYNE stock moved upwards by 2.9% to $10.85.
• Teva Pharmaceutical Indus, Inc. TEVA stock surged 2.7% to $7.13. The market cap stands at $7.3 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $9.00.
• DBV Technologies, Inc. DBVT stock rose 2.6% to $9.12. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
• CannTrust Holdings, Inc. CTST stock moved upwards by 2.4% to $1.70. The market cap stands at $320.7 million.
• Nabriva Therapeutics, Inc. NBRV shares rose 2.4% to $2.15. The market cap seems to be at $176.8 million.

Losers

• Solid Biosciences, Inc. SLDB stock fell 8.7% to $8.30 during Thursday's pre-market session. The market cap seems to be at $321.5 million. The most recent rating by Citigroup, on August 29, is at Sell, with a price target of $6.00.
• DelMar Pharmaceuticals, Inc. DMPI shares fell 6.5% to $0.62.
• VIVUS, Inc. VVUS stock plummeted 4.7% to $4.04. The market value of their outstanding shares is at $23.7 million.
• T2 Biosystems, Inc. TTOO stock decreased by 3.6% to $1.35. The market cap stands at $209.3 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
• Vical, Inc. VICL stock fell 2.0% to $0.88. The market cap seems to be at $16.2 million